Mayo Clinic, Hennepin Healthcare Institute Join on Transplant Policy

Mayo Clinic and Hennepin Healthcare Research Institute (HHRI) are combining clinical, research and data expertise through the Center for Policy and Outcomes Research in Transplantation (CPORT) to shape transplant policy. One of the first centers of its kind, CPORT aims to translate evidence into meaningful change across the transplant system and ultimately help more patients receive lifesaving transplants.

Together, Mayo Clinic and HHRI investigators will study how allocation policies, emerging technologies and other changes to the donation and transplantation system affect access, equity and patient outcomes.

Portrait of Dr. W Ray Kim
W Ray Kim, M.D.

"As physicians, we see firsthand what it means for a patient to wait for a lifesaving organ," says W Ray Kim, M.D., transplant hepatologist and director of CPORT at Mayo Clinic. "CPORT was created to look beyond the challenges facing one patient or one entity and focus on what we can change across the system to improve transplantation for patients everywhere."

More than 100,000 people are on the national transplant waiting list. With demand for lifesaving organ transplants continuing to exceed the supply of available organs, national policies and the adoption of new approaches across the transplant system can significantly affect patients' access to transplantation and how long they wait.

Portrait of Dr. Jon Snyder
Jon Snyder, Ph.D.

"National transplant data give us the ability to identify patterns, understand variation and see where opportunities for improvement exist," says Jon Snyder, Ph.D., director of transplant epidemiology at HHRI. "Bringing those insights together with clinical experience can help us focus on the questions that matter most for the future of donation and transplantation."

Building upon a history of translating transplant research into policy

More than two decades ago, Dr. Kim and colleagues helped develop the Model for End-Stage Liver Disease (MELD) score, which predicts a patient's risk of death without a liver transplant. MELD was adopted for U.S. liver allocation in 2002, shifting allocation away from waiting time and toward medical urgency, and it subsequently became widely used internationally.

CPORT builds on that evidence-to-policy approach, applying lessons from liver allocation to some of the most pressing challenges across the system.

For more than two decades, HHRI has supported the donation and transplantation community through in-depth data analysis, statistical modeling and simulations of the solid organ transplant system, providing insights that help inform transplant patients and other community stakeholders.

Research and collaboration in action

Current research spans several areas of transplantation across Mayo Clinic, including using machine perfusion technology to potentially expand the donor organ pool, improving the organ-offer and allocation process, addressing disparities in transplantation and exploring novel organ replacement strategies.

/Public Release, Courtesy: Mayo Clinic. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.